The landscape of wearable sensors in clinical trials has proven difficult to navigate for many, including sponsors and vendors.

Collaboration around the development of digital endpoints with a focus on data quality, validation, compliance, and clinical utility is required to extract the most from new digital technologies.

In this 20-minute presentation, VivoSense Chief Science Officer, Kate Lyden, PhD., and Jeremy Wyatt,  ActiGraph CEO, discuss:

1. Characteristics of clinically meaningful endpoints
2. The data behind developing a novel digital biomarker called the Best 6 Minute Effort (B6ME) an outcome assessment that can augment the in-clinic 6 Minute Walk Test (6MWT) with real-world data collected from a wearable sensor
3. Steps for future development

Fill out the form to watch the presentation today!